Jianjin Pharma

Jianjin Pharmaceutical is a pharmaceutical enterprise that has passed the U.S. Food and Drug Administration (U.S. FDA) on-site inspection certification with zero deficiencies. To date, Jianjin Pharmaceutical has successfully passed U.S. FDA on-site inspections three times.

Adhering to the corporate mission of "a professional team dedicated to high-quality injectable drugs," we are always committed to bringing safer pharmaceutical technology achievements to every patient, instilling confidence in life and health.

Since its construction and operation began in December 2006, Jianjin Pharmaceutical has always paid high attention to "drug safety." It pioneered the introduction of the "Quality by Design" concept advocated by the U.S. Food and Drug Administration (U.S. FDA), strictly constructed and operated in accordance with U.S. FDA and cGMP standards, adopted fully enclosed isolation technology, integrated globally advanced pharmaceutical process equipment, and assembled and built a professional pharmaceutical team characterized by "integrity and promise-keeping, customer orientation, safety and efficiency, and continuous improvement."

To ensure and fulfill the commitments to "drug safety" and "high-quality injectable drugs," Jianjin Pharmaceutical continuously invests global resources, with actual investment nearing 80 million US dollars. The total investment in the first phase will exceed 100 million US dollars, and capacity expansion projects have now been initiated.

Jianjin Pharmaceutical boasts a team of professionally qualified and well-trained practitioners, establishing a dynamic, highly skilled, and excellence-seeking work team. Since its inception, our team has brought together numerous outstanding pharmaceutical industry experts from home and abroad, and has cultivated a group of young and excellent technical talents. We carefully and rigorously select each new employee, and through a comprehensive GMP training system, provide employees with necessary job-specific training to ensure that all operations and standards are correctly executed and supervised, thereby fulfilling Jianjin Pharmaceutical's commitments to product quality and regulatory compliance.

Jianjin Pharmaceutical focuses on the research, development, and production of high-end injectable drugs. Leveraging its comprehensive advantages, it concentrates on developing and manufacturing high-value-added injectable products for the treatment of major diseases, including: anti-tumor, anti-infective, cardiovascular, pre-filled syringes, and other commonly used clinical drugs, involving new fields such as liposomes and nanotechnology, macromolecular biologics, sustained and controlled release formulations, and targeted drugs.

In July 2012, Jianjin Pharmaceutical passed the U.S. Food and Drug Administration (U.S. FDA) certification inspection as a whole. In 2013, its sterile formulation products for cancer treatment were approved to enter the U.S. medical market, becoming among the first batch of sterile injectable products for major diseases directly exported to the United States from China.


We will provide you with:
A good working environment and humane management;
Challenging and passionate work, and a variety of interest groups;
Competitive salary: annual salary increase plan;
Comprehensive training plans and personal career development system;
Comprehensive welfare system: five insurances and one housing fund upon entry, shuttle bus service, free lunch, holiday benefits, paid annual leave, statutory holidays, long-term contribution awards, etc.